E. J. H.
This content is PDF only. Please click on the PDF icon to access.
Hemodialysis for chronic renal failure is being widely used in North America and Europe to an extent that could not have been predicted 10 years ago. Its benefits are, however, accompanied by risks not the least of which are those of infection, either in patient or staff. One of these risks, hepatitis, was reported in the July ANNALS, from the Charing Cross Hospital Medical School, London, England, by John B. Eastwood and associates (1). This risk and that of shunt sepsis were discussed at length, along with detailed suggestions for minimizing these hazards, in the August
H. EJ. More Notes on Recent ANNALS Themes. Ann Intern Med. ;70:230–231. doi: 10.7326/0003-4819-70-1-230
Download citation file:
Published: Ann Intern Med. 1969;70(1):230-231.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use